Passive targeting of ischemic-reperfused myocardium with adenosine-loaded silica nanoparticles

Por Galagudza, Michael, Korolev, Dmitry, Postnov, Viktor, Naumisheva, Elena, Grigorova, Yulia, Uskov, Ivan, Shlyakhto, Eugene
Publicado em 2012

Aortic Fibrosis, Induced by High Salt Intake in the Absence of Hypertensive Response, Is Reduced by a Monoclonal Antibody to Marinobufagenin

Por Grigorova, Yulia N., Juhasz, Ondrej, Zernetkina, Valentina, Fishbein, Kenneth W., Lakatta, Edward G., Fedorova, Olga V., Bagrov, Alexei Y.
Publicado no Am J Hypertens (2016)

Magnesium Sulfate Potentiates Effect of Digifab on Marinobufagenin-Induced Na/K-ATPase Inhibition

Por Zazerskaya, Irina E., Ishkaraeva, Valentina V., Frolova, Elena V., Solodovnikova, Nelly G., Grigorova, Yulia N., David Adair, C., Fedorova, Olga V., Bagrov, Alexei Y.
Publicado em 2013

Synthesis of an Endogenous Steroidal Na Pump Inhibitor Marinobufagenin, Implicated in Human Cardiovascular Diseases, Is Initiated by CYP27A1 via Bile Acid Pathway

Por Fedorova, Olga V., Zernetkina, Valentina I., Shilova, Victoria Y., Grigorova, Yulia N., Juhasz, Ondrej, Wei, Wen, Marshall, Courtney A., Lakatta, Edward G., Bagrov, Alexei Y.
Publicado no Circ Cardiovasc Genet (2015)

Dietary Sodium Restriction Reduces Arterial Stiffness, Vascular TGF-β-Dependent Fibrosis and Marinobufagenin in Young Normotensive Rats

Por Grigorova, Yulia N., Wei, Wen, Petrashevskaya, Natalia, Zernetkina, Valentina, Juhasz, Ondrej, Fenner, Rachel, Gilbert, Christian, Lakatta, Edward G., Shapiro, Joseph I., Bagrov, Alexei Y., Fedorova, Olga V.
Publicado no Int J Mol Sci (2018)

Cardiotonic Steroids Induce Vascular Fibrosis Via Pressure-Independent Mechanism in NaCl-Loaded Diabetic Rats

Por Fedorova, Olga V., Fadeev, Artem V., Grigorova, Yulia N., Marshall, Courtney A., Zernetkina, Valentina, Kolodkin, Nikolai I., Agalakova, Natalia I., Konradi, Alexandra O., Lakatta, Edward G., Bagrov, Alexei Y.
Publicado no J Cardiovasc Pharmacol (2019)

Marinobufagenin-induced vascular fibrosis is a likely target for mineralocorticoid antagonists

Por Fedorova, Olga V., Emelianov, Igor V., Bagrov, Konstantin A., Grigorova, Yulia N., Wei, Wen, Juhasz, Ondrej, Frolova, Elena V., Marshall, Courtney A., Lakatta, Edward G., Konradi, Alexandra O., Bagrov, Alexei Y.
Publicado no J Hypertens (2015)

Antibody to Marinobufagenin Reverses Placenta-Induced Fibrosis of Umbilical Arteries in Preeclampsia

Por Fedorova, Olga V., Ishkaraeva, Valentina V., Grigorova, Yulia N., Reznik, Vitaly A., Kolodkin, Nikolai I., Zazerskaya, Irina E., Zernetkina, Valentina, Agalakova, Natalia I., Tapilskaya, Natalia I., Adair, C. David, Lakatta, Edward G., Bagrov, Alexei Y.
Publicado no Int J Mol Sci (2018)

Monoclonal Antibody to Marinobufagenin Downregulates TGFβ Profibrotic Signaling in Left Ventricle and Kidney and Reduces Tissue Remodeling in Salt‐Sensitive Hypertension

Por Zhang, Yongqing, Wei, Wen, Shilova, Victoria, Petrashevskaya, Natalia N., Zernetkina, Valentina I., Grigorova, Yulia N., Marshall, Courtney A., Fenner, Rachel C., Lehrmann, Elin, Wood, William H., Becker, Kevin G., Lakatta, Edward G., Bagrov, Alexei Y., Fedorova, Olga V.
Publicado no J Am Heart Assoc (2019)